Jeong Rang Park Tae Sik Jung Jung Hwa Jung Gyeong-Won Lee Me Ae Kim Ki-Jong Park Deok Ryong Kim Se-Ho Chang Soon Il Chung Jong Ryeal Hahm
10.3346/jkms.2005.20.3.502
J Korean Med Sci
2005 Jun;20(3):502-5.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/15953878/
Diabetes Mellitus, Type 2 / complications Hyperlipoproteinemia Type V / complications Hypothyroidism / complications Xanthomatosis / complications
Diabetes Mellitus, Type 2 / complications Hyperlipoproteinemia Type V / complications Hypothyroidism / complications Xanthomatosis / complications Case Reports Research Support, Non-U.S. Gov't Diabetes Mellitus, Type 2 / blood Diabetes Mellitus, Type 2 / drug therapy Erythrocyte Aggregation Female Fenofibrate / therapeutic use Humans Hyperlipidemias / blood Hyperlipoproteinemia Type V / blood Hyperlipoproteinemia Type V / drug therapy Hypoglycemic Agents / therapeutic use Hypolipidemic Agents / therapeutic use Hypothyroidism / blood Hypothyroidism / drug therapy Middle Aged Skin Diseases / blood Skin Diseases / complications Skin Diseases / drug therapy Thyrotropin / blood Thyrotropin / therapeutic use Thyroxine / blood Treatment Outcome Xanthomatosis / blood Xanthomatosis / drug therapy Hypoglycemic Agents Hypolipidemic Agents Thyrotropin Thyroxine Fenofibrate
PMC2782212
15953878
A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas
2005